Asset Management One Co. Ltd. Sells 4,489 Shares of Encompass Health Co. (NYSE:EHC)

Asset Management One Co. Ltd. trimmed its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 27.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,745 shares of the company's stock after selling 4,489 shares during the period. Asset Management One Co. Ltd.'s holdings in Encompass Health were worth $1,099,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of EHC. MassMutual Private Wealth & Trust FSB lifted its position in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after buying an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new position in Encompass Health during the third quarter valued at approximately $40,000. Tompkins Financial Corp acquired a new position in shares of Encompass Health during the fourth quarter worth $46,000. Morse Asset Management Inc bought a new stake in shares of Encompass Health in the third quarter worth $68,000. Finally, Point72 Asia Singapore Pte. Ltd. increased its stake in shares of Encompass Health by 62.0% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 1,095 shares of the company's stock worth $106,000 after buying an additional 419 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently commented on EHC. Barclays upped their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. KeyCorp upped their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. William Blair reissued an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Finally, Royal Bank of Canada reissued an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Encompass Health has a consensus rating of "Buy" and a consensus price target of $107.67.

Remove Ads

Encompass Health Stock Up 1.4 %

Shares of EHC traded up $1.33 during trading hours on Monday, reaching $98.86. The company's stock had a trading volume of 465,200 shares, compared to its average volume of 655,234. The firm has a market cap of $9.96 billion, a price-to-earnings ratio of 22.17, a P/E/G ratio of 2.31 and a beta of 0.90. Encompass Health Co. has a 1-year low of $73.68 and a 1-year high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company has a 50 day moving average of $96.01 and a two-hundred day moving average of $96.05.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, research analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health's dividend payout ratio is currently 15.25%.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares of the company's stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is currently owned by corporate insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.